X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13338) 13338
Newspaper Article (157) 157
Magazine Article (49) 49
Book Chapter (7) 7
Book / eBook (6) 6
Conference Proceeding (3) 3
Publication (3) 3
Reference (3) 3
Web Resource (3) 3
Dissertation (2) 2
Government Document (2) 2
Newsletter (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11964) 11964
iodine radioisotopes - therapeutic use (8923) 8923
male (6630) 6630
female (6388) 6388
middle aged (4984) 4984
adult (4477) 4477
aged (3687) 3687
iodine radioisotopes (2979) 2979
animals (2246) 2246
thyroid neoplasms - radiotherapy (2225) 2225
radiology, nuclear medicine & medical imaging (1967) 1967
oncology (1811) 1811
treatment outcome (1667) 1667
radiotherapy dosage (1662) 1662
cancer (1654) 1654
thyroidectomy (1647) 1647
radionuclide imaging (1560) 1560
adolescent (1501) 1501
follow-up studies (1454) 1454
therapy (1392) 1392
endocrinology & metabolism (1349) 1349
brachytherapy (1334) 1334
retrospective studies (1312) 1312
thyroid neoplasms - pathology (1295) 1295
iodine radioisotopes - adverse effects (1267) 1267
mice (1165) 1165
iodine (1156) 1156
thyroid neoplasms - surgery (1148) 1148
carcinoma (1126) 1126
combined modality therapy (1112) 1112
aged, 80 and over (1103) 1103
radiotherapy (1095) 1095
brachytherapy - methods (1044) 1044
child (1029) 1029
time factors (996) 996
thyroid cancer (979) 979
prostatic neoplasms - radiotherapy (949) 949
radioisotopes (885) 885
radiopharmaceuticals - therapeutic use (877) 877
prognosis (861) 861
iodine radioisotopes - administration & dosage (835) 835
iodine radioisotopes - pharmacokinetics (832) 832
thyroid neoplasms - therapy (796) 796
care and treatment (770) 770
hyperthyroidism - radiotherapy (768) 768
thyroid neoplasms - diagnostic imaging (759) 759
hyperthyroidism (732) 732
surgery (723) 723
dosimetry (710) 710
nuclear medicine (700) 700
graves disease - radiotherapy (675) 675
antibodies, monoclonal - therapeutic use (673) 673
medicine & public health (645) 645
patients (618) 618
tissue distribution (610) 610
radioimmunotherapy (606) 606
antithyroid agents - therapeutic use (598) 598
isotopes (591) 591
management (583) 583
risk factors (561) 561
tumors (559) 559
young adult (537) 537
radioiodine therapy (520) 520
rats (518) 518
medicine (516) 516
tomography, x-ray computed (504) 504
neoplasm staging (500) 500
radiology (498) 498
carcinoma, papillary - radiotherapy (496) 496
i-131 (488) 488
radiology and nuclear medicine (488) 488
mice, nude (487) 487
diagnosis (486) 486
thyroglobulin - blood (480) 480
thyroid neoplasms - diagnosis (469) 469
thyroid (463) 463
radiation dosage (454) 454
thyrotropin - blood (453) 453
medicine, general & internal (449) 449
thyroid function tests (449) 449
child, preschool (448) 448
health aspects (437) 437
iodine isotopes (437) 437
prospective studies (432) 432
neoplasm metastasis (430) 430
radioactive iodine (427) 427
thyroxine - therapeutic use (427) 427
recurrence (419) 419
pharmacology & pharmacy (418) 418
follow-up (414) 414
diseases (412) 412
radioiodine (411) 411
papillary (410) 410
antineoplastic agents - therapeutic use (409) 409
radiation therapy (409) 409
dose-response relationship, radiation (407) 407
radioisotopes - therapeutic use (404) 404
lymphatic metastasis (402) 402
brachytherapy - adverse effects (398) 398
survival rate (397) 397
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12039) 12039
German (609) 609
French (280) 280
Japanese (208) 208
Spanish (168) 168
Russian (132) 132
Chinese (126) 126
Italian (93) 93
Polish (78) 78
Portuguese (61) 61
Dutch (43) 43
Hungarian (31) 31
Czech (27) 27
Danish (22) 22
Swedish (18) 18
Croatian (8) 8
Finnish (8) 8
Hebrew (8) 8
Bulgarian (7) 7
Norwegian (7) 7
Romanian (7) 7
Serbian (4) 4
Korean (3) 3
Slovak (3) 3
Ukrainian (3) 3
Lithuanian (2) 2
Arabic (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 906 - 918
Summary Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the... 
Internal Medicine | ANTITHYROID DRUG-TREATMENT | SUBACUTE THYROIDITIS | MEDICINE, GENERAL & INTERNAL | RADIOIODINE THERAPY | SENSITIVE THYROTROPIN | PAINLESS THYROIDITIS | GRAVES-DISEASE | THYROTROPIN-RECEPTOR | CLINICAL ENDOCRINOLOGISTS GUIDELINES | CONSENSUS STATEMENT | AMERICAN THYROID ASSOCIATION | Graves Disease - diagnosis | Hyperthyroidism - diagnosis | Humans | Thyroid Crisis - therapy | Patient Care Team | Thyrotoxicosis - metabolism | Hyperthyroidism - metabolism | Thyrotoxicosis - drug therapy | Amiodarone - administration & dosage | Iodine Radioisotopes - adverse effects | Amiodarone - adverse effects | Iodine Radioisotopes - therapeutic use | Thyroid Hormones - blood | Female | Pregnancy Complications - metabolism | Hyperthyroidism - epidemiology | Adrenergic beta-Antagonists - therapeutic use | Graves Disease - metabolism | Antithyroid Agents - adverse effects | Diagnosis, Differential | Thyroid Hormones - biosynthesis | Drug Administration Schedule | Risk Factors | Antithyroid Agents - therapeutic use | Hyperthyroidism - therapy | Pregnancy Complications - diagnosis | Antithyroid Agents - administration & dosage | Graves Disease - therapy | Thyroidectomy - adverse effects | Thyrotoxicosis - diagnosis | Pregnancy | Iodine Radioisotopes - administration & dosage | Thyroid Crisis - diagnosis | Thyroid Gland - metabolism | Practice Guidelines as Topic | Pregnancy Complications - therapy | Medical colleges | Thyroid gland | Thyroid hormones | Radiotherapy | Adrenergic beta blockers | Hyperthyroidism | Hormones | Health risk assessment | Drug dosages | Iodine
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 5, pp. 1323 - 1329
Purpose To report outcomes for 1,111 men treated with iodine-125 brachytherapy (BT) at a single institution. Methods and Materials A total of 1,111 men (median... 
Radiology | Hematology, Oncology and Palliative Medicine | Prostate neoplasms | Brachytherapy | Radiotherapy | Prostate-specific antigen | LONG-TERM URINARY | SEXUAL FUNCTION | CANCER | FAILURE | IMPACT | ERECTILE FUNCTION | ONCOLOGY | RECOMMENDATIONS | CONFORMAL RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SURVIVAL OUTCOMES | HORMONAL-THERAPY | Prostatic Neoplasms - radiotherapy | Adenocarcinoma - pathology | Prospective Studies | Humans | Middle Aged | Male | Iodine Radioisotopes - therapeutic use | Aged, 80 and over | Prostatic Neoplasms - blood | Adenocarcinoma - radiotherapy | Radiotherapy Dosage | Prostatic Neoplasms - pathology | Adenocarcinoma - blood | Brachytherapy - methods | Proportional Hazards Models | Urination Disorders - drug therapy | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Disease-Free Survival | Neoadjuvant Therapy - methods | Aged | Penile Erection - physiology | Neoplasm Staging | Ontario | Prostate | Brachytherapy - adverse effects | Adenocarcinoma - mortality | Radioisotope brachytherapy | Hospitals | Ants | INTERMEDIATE MASS NUCLEI | BIOPSY | MALE GENITALS | ANTIGENS | MEDICINE | IODINE 125 | INTERNAL CONVERSION RADIOISOTOPES | MATHEMATICS | MULTIVARIATE ANALYSIS | THERAPY | GLANDS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | RADIOLOGY | PROSTATE | DIAGNOSTIC TECHNIQUES | NEOPLASMS | STATISTICS | RADIOISOTOPES | NUCLEAR MEDICINE | ODD-EVEN NUCLEI | ELECTRON CAPTURE RADIOISOTOPES | ISOTOPES | ORGANS | IODINE ISOTOPES | DISEASES | NUCLEI | DAYS LIVING RADIOISOTOPES | BRACHYTHERAPY | BODY | HAZARDS | HORMONES
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 5, pp. 1433 - 1438
... excellent (1, 2) . International guidelines do not suggest the use of PB for intermediate- and high-risk patients, for whom it is considered less effective (3–5... 
Radiology | Hematology, Oncology and Palliative Medicine | brachytherapy | Prostate cancer | Monotherapy | Survival | Biochemical recurrence | RADICAL PROSTATECTOMY | CANCER | FAILURE | RADIATION-THERAPY | SEED IMPLANTATION | EXTERNAL-BEAM RADIOTHERAPY | ESTRO/EAU/EORTC RECOMMENDATIONS | ONCOLOGY | EXPERIENCE | DOSIMETRY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Adenocarcinoma - pathology | Adenocarcinoma - blood | Humans | Middle Aged | Brachytherapy - methods | Male | Survival Rate | Treatment Outcome | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Prostate - pathology | Regression Analysis | Iodine Radioisotopes - therapeutic use | Androgen Antagonists - therapeutic use | Prostatic Neoplasms - blood | Aged | Adenocarcinoma - mortality | Adenocarcinoma - radiotherapy | INTERMEDIATE MASS NUCLEI | MALE GENITALS | MEDICINE | IODINE 125 | INTERNAL CONVERSION RADIOISOTOPES | MATHEMATICS | MULTIVARIATE ANALYSIS | THERAPY | GLANDS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | REGRESSION ANALYSIS | RADIOTHERAPY | RADIOLOGY | PROSTATE | NEOPLASMS | STATISTICS | RADIOISOTOPES | NUCLEAR MEDICINE | ODD-EVEN NUCLEI | ELECTRON CAPTURE RADIOISOTOPES | ISOTOPES | ORGANS | IODINE ISOTOPES | DISEASES | NUCLEI | DAYS LIVING RADIOISOTOPES | BRACHYTHERAPY | BODY | SURVIVAL CURVES
Journal Article
Thyroid (New York, N.Y.), ISSN 1050-7256, 09/2017, Volume 27, Issue 9, pp. 1135 - 1141
Background: While there is a clear consensus for defining radioiodine-refractory differentiated thyroid cancer (RR-DTC), it is unknown whether these criteria... 
Phase 3 | radioiodine therapy | thyroid cancer | multitargeted kinase inhibitor | lenvatinib | MANAGEMENT | METASTASES | KINASE | PHASE-3 | ANTITUMOR ACTIVITIES | E7080 | THERAPY | ENDOCRINOLOGY & METABOLISM | INHIBITOR | Follow-Up Studies | Tumor Burden - radiation effects | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Iodine Radioisotopes - adverse effects | Tissue Distribution | Iodine Radioisotopes - therapeutic use | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Treatment Failure | Aged, 80 and over | Adult | Female | Radiopharmaceuticals - pharmacokinetics | Thyroid Neoplasms - mortality | Double-Blind Method | Phenylurea Compounds - therapeutic use | Terminology as Topic | Thyroid Neoplasms - radiotherapy | Iodine Radioisotopes - pharmacokinetics | Cross-Over Studies | Radiopharmaceuticals - administration & dosage | Iodine Radioisotopes - administration & dosage | Thyroid Neoplasms - drug therapy | Tumor Burden - drug effects | Protein Kinase Inhibitors - therapeutic use | Survival Analysis | Aged | Quinolines - therapeutic use | Radiopharmaceuticals - adverse effects | Dose-Response Relationship, Radiation | Quinolines - adverse effects | Radiopharmaceuticals - therapeutic use | Thyroid Neoplasms - pathology | Thyroid Cancer and Nodules
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 1, pp. 50 - 56
Journal Article
Journal Article
Brachytherapy, ISSN 1538-4721, 2016, Volume 16, Issue 1, pp. 68 - 74
Abstract Brachytherapy is the use of radionuclides to treat malignancies or benign conditions by means of a radiation source placed close to or into the tumor or treatment site... 
Radiology | Hematology, Oncology and Palliative Medicine | Treatment goals | Radionuclides | Radionuclide brachytherapy | Endometrial cancer | Low-dose-rate brachytherapy | Bronchial lesions | Breast cancer | LDR brachytherapy | LDR applicators | Radiation safety | Obstructive bile duct lesions | Pulse-dose-rate brachytherapy | Head and neck cancer | Brachytherapy | Esophageal lesions | Prostate cancer | Treatment planning | STATEMENT | CONSENSUS GUIDELINES | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | LOCALLY ADVANCED-CARCINOMA | Endometrial Neoplasms - radiotherapy | Prostatic Neoplasms - radiotherapy | United States | Humans | Iridium Radioisotopes - therapeutic use | Male | Esophageal Neoplasms - radiotherapy | Bile Duct Neoplasms - radiotherapy | Iodine Radioisotopes - therapeutic use | Societies, Medical | Female | Neoplasms - radiotherapy | Yttrium Radioisotopes - therapeutic use | Radiotherapy Dosage | Radioisotopes - therapeutic use | Uterine Cervical Neoplasms - radiotherapy | Brachytherapy - methods | Cesium Radioisotopes - therapeutic use | Radium - therapeutic use | Head and Neck Neoplasms - radiotherapy | Breast Neoplasms - radiotherapy | Bronchial Neoplasms - radiotherapy | Palladium - therapeutic use | Radiation Oncology | Palladium | Universities and colleges | Radioisotope brachytherapy | Radiology, Medical
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 297 - 304
.... The PTVi were prospectively used to generate implants using mixtures of isotopes. For mixed-radioisotope implants, we also... 
Radiology | Hematology, Oncology and Palliative Medicine | Brachytherapy | Dual isotopes | Radiobiologic model | Prostate | Focal therapy | RADIONUCLIDES | VOLUME | RADICAL PROSTATECTOMY | ALPHA/BETA-RATIO | DOSE-ESCALATION | ONCOLOGY | REPOPULATION | RADIOTHERAPY | OUTCOMES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | GLEASON SCORE | Organs at Risk - radiation effects | Prostatic Neoplasms - radiotherapy | Radiotherapy Planning, Computer-Assisted - methods | Humans | Half-Life | Male | Prostatic Neoplasms - diagnosis | Feasibility Studies | Prostate - pathology | Iodine Radioisotopes - therapeutic use | Ultrasonography | Prostatic Neoplasms - diagnostic imaging | Retrospective Studies | Urethra - radiation effects | Radiotherapy Dosage | Radioisotopes - therapeutic use | Magnetic Resonance Spectroscopy | Brachytherapy - methods | Prostate - radiation effects | Organ Size | Cesium Radioisotopes - therapeutic use | Rectum - radiation effects | Tumor Burden | Magnetic Resonance Imaging | Radiation Injuries - prevention & control | Models, Biological | Palladium - therapeutic use | Prostate - diagnostic imaging | Relative Biological Effectiveness | Brachytherapy - adverse effects | Care and treatment | Health aspects | Prostate cancer | Radiation | Cancer | GASTROINTESTINAL TRACT | LARGE INTESTINE | INTERMEDIATE MASS NUCLEI | DIGESTIVE SYSTEM | MALE GENITALS | RADIATION DOSES | IMPLANTS | MEDICINE | IODINE 125 | PALLADIUM 103 | INTERNAL CONVERSION RADIOISOTOPES | IRRADIATION | NMR IMAGING | THERAPY | CESIUM 131 | GLANDS | BIOLOGICAL EFFECTS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOLOGY | RADIATION SOURCE IMPLANTS | PROSTATE | DIAGNOSTIC TECHNIQUES | PALLADIUM ISOTOPES | NEOPLASMS | RECTUM | RADIATION SOURCES | RADIOISOTOPES | INTESTINES | NUCLEAR MEDICINE | ODD-EVEN NUCLEI | ELECTRON CAPTURE RADIOISOTOPES | ISOTOPES | URINARY TRACT | ORGANS | IODINE ISOTOPES | DISEASES | NUCLEI | CESIUM ISOTOPES | DOSES | DAYS LIVING RADIOISOTOPES | EVEN-ODD NUCLEI | BRACHYTHERAPY | BODY
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 18, pp. 1663 - 1673
This trial compared two thyrotropin-stimulation methods and two 131I doses for postoperative ablation in patients with low-risk thyroid cancer. Rates of... 
RECOMBINANT HUMAN THYROTROPIN | CARCINOMA PATIENTS | MEDICINE, GENERAL & INTERNAL | STIMULATED THYROGLOBULIN | REMNANT ABLATION | HORMONE WITHDRAWAL | FOLLOW-UP | PREDICTIVE-VALUE | SERUM THYROGLOBULIN LEVELS | QUALITY-OF-LIFE | RADIOACTIVE IODINE | Adenocarcinoma, Follicular - radiotherapy | Follow-Up Studies | Neck - diagnostic imaging | Humans | Middle Aged | Ablation Techniques | Male | Iodine Radioisotopes - adverse effects | Iodine Radioisotopes - therapeutic use | Thyrotropin - adverse effects | Thyroid Hormones - blood | Adenocarcinoma, Follicular - drug therapy | Ultrasonography | Adult | Female | Thyrotropin - therapeutic use | Thyroid Hormones - therapeutic use | Adenocarcinoma, Follicular - surgery | Thyroid Neoplasms - surgery | Carcinoma, Papillary - drug therapy | Treatment Outcome | Combined Modality Therapy | Thyroid Neoplasms - radiotherapy | Carcinoma, Papillary - surgery | Thyroidectomy | Hypothyroidism - etiology | Carcinoma, Papillary - radiotherapy | Thyroid Neoplasms - drug therapy | Quality of Life | Drugs | Dose-response relationship (Biochemistry) | Treatment outcome | Evaluation | Usage | Care and treatment | Patient outcomes | Radiofrequency ablation | Product/Service Evaluations | Thyroid cancer | Thyrotropin | Dosage and administration | Drug therapy, Combination | Drug therapy | Isotopes | Iodine | Event-related potentials | Thyroid gland | Ablation | Contamination | Thyroid carcinoma | Metastases | Thyroid-stimulating hormone | Thyroglobulin | Neck | Ultrasound | Cancer | Thyroid
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2017, Volume 98, Issue 2, pp. 275 - 285
Journal Article